8-K/A XBRL

FORM 8-K/A

Company: Theravance Biopharma, Inc.
Filed: October 5, 2021
Period of Report: September 15, 2021
Accession Number: 0001104659-21-123200

View Document ↗ View on SEC.gov ↗